IMA MED-TECH and IMA Active are pleased to be Silver Sponsor of in theInternational conference Exploring the Future of Inhalation Drug Delivery, which will be held in Parma (Italy) on September 8-10, 2026.
The International Conference “Exploring the Future of Inhalation Drug Delivery“, is organized by the University of Parma and supported by the Galenus Foundation. The conference will focus on the latest advancements in the formulation and development of inhaled medicines. This dynamic sector is experiencing continuous evolution, with a heightened focus on the introduction of innovative medicines designed for both local and systemic treatment. The thematic sessions will delve into various aspects, including the inhalation of biologics such as proteins or DNA/RNA-based therapies, novel treatments for unmet diseases (such as cough, cancer, lung infection, and idiopathic pulmonary fibrosis), MDI propellant transition, and nose-to-brain delivery.
A dedicated scientific session will specifically be committed to young researchers, providing a platform for them to showcase their work and fostering the promotion of their research initiatives. The conference serves as a unique opportunity to present and exchange research achievements, offering a forum for interaction with prominent researchers and companies within this specialized field.
Several distinguished speakers with a high international reputation in the development of inhalation products have already confirmed their participation, further elevating the caliber of the event.
Do not miss the opportunity to meet MA MED-TECH and IMA Active DPIs experts during the exhibition session where we will showcase our advanced technologies for Dry Powder Inhaler (DPI) processing and assembly. Backed by decades of expertise, IMA provides industry-leading solutions to meet the growing demands of the pharmaceutical and medical device industries.
IMA MED-TECH and IMA Active are also sponsoring the the “Pitch Contest in Respiratory Disease” that will take place on September 11th 2026, in Parma (IT).
This event is designed to provide experience-based guidance to entrepreneurial scientists as they consider transitioning an idea from the bench into development as a drug, drug product or other innovation in respiratory disease.